Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 05, 2015 4:20 PM ET

Health Care Technology

Company Overview of Theranos, Inc.

Company Overview

Theranos, Inc. operates as a consumer healthcare technology company. It specializes in the areas of oncology, pediatrics, and geriatrics. The company designs, develops, and manufactures systems that provide access to health information for the early detection and intervention of diseases; and conducts laboratory tests from blood, urine, fluid, solid, and other samples. It also provides a suite of tools for patients and doctors ranging from Websites to mobile applications. The company was founded in 2003 and is based in Palo Alto, California.

1601 South California Avenue

Palo Alto, CA 94304

United States

Founded in 2003

Phone:

650-838-9292

Fax:

650-838-9165

Key Executives for Theranos, Inc.

Founder, Chairman and Chief Executive Officer
President, Chief Operating Officer and Director
Vice President of Finance & Operations
Chief Creative Officer
General Counsel
Compensation as of Fiscal Year 2015.

Theranos, Inc. Key Developments

Theranos, Inc. Receives U.S. Food and Drug Administration’s Clearance of its Test System and Test for Herpes Simplex 1 Virus IgG

Theranos, Inc. announced that it has received the U.S. Food and Drug Administration’s (FDA) clearance of its test system and test for herpes simplex 1 virus IgG. The FDA’s decision provides independent validation of Theranos’ patented finger stick and venous blood testing technology and the ground breaking Theranos System upon which the HSV-1 IgG test is run, as well as the approach that the company has supported for FDA review of Laboratory Developed Tests (LDTs). The FDA decision involved extensive review of the Theranos System. The FDA clearance includes the use of Theranos’ Nanotainer™ Tubes for tests run by this method, which allow samples to be collected from just a few drops of blood from a virtually painless prick of a patient’s finger. The Theranos System, including Theranos’ device, analytical software, and Nanotainer™ Tubes, has been fully validated and cleared for use with this test method. FDA’s review process for 510(k) notifications is widely recognized as one of the most rigorous regulatory hurdles in the world for evaluation of the performance, accuracy, and intended use of diagnostic tests. Today’s announcement demonstrates that Theranos has met that standard and is an important step in Theranos’ mission to make health information accessible to people at the time it matters, enabling early detection and prevention of disease, and empowering individuals everywhere with information to live healthier lives – a mission that depends on patients knowing they are getting results they can trust.

Theranos, Inc. Appoints Heather King as General Counsel

Theranos, Inc. announced that Heather King has been appointed as General Counsel. King has been a partner at Boies, Schiller & Flexner in their Washington, D.C. office and has worked closely with their client, Theranos. King, who will be moving to Palo Alto. Before joining Boies, Schiller & Flexner, King served as Special Assistant and Policy Advisor to U.S. Senator Hillary Rodham Clinton, and helped lead Senator Clinton’s campaigns.

Theranos, Inc. Appoints H. Foege as Director

Theranos, Inc. announced the appointment of William H. Foege, M.D., M.P.H., to its Board of Directors. Dr. Foege, an epidemiologist and former director of the U.S. Center for Disease Control and Prevention, has left an indelible mark on the field of global health. Recognized as the health innovator behind the successful campaign to eradicate smallpox in the 1970s, Dr. Foege received the Presidential Medal of Freedom in 2012, the nation's high civilian honor. He was a senior medical advisor for the Bill and Melinda Gates Foundation from 1999 until his retirement in 2011.

Similar Private Companies By Industry

Company Name Region
eLux Medical, Inc. United States
Tutela Industies, LLC United States
PhysioAdvantage, LLC United States
Full Spectrum Software, Inc. United States
Viewics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Theranos, Inc., please visit www.theranos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.